You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 18, 2025

Drug Price Trends for HM ASPIRIN EC


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for HM ASPIRIN EC

Average Pharmacy Cost for HM ASPIRIN EC

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
HM ASPIRIN EC 81 MG TABLET 62011-0019-01 0.01553 EACH 2025-03-19
HM ASPIRIN EC 81 MG TABLET 62011-0019-01 0.01473 EACH 2025-02-19
HM ASPIRIN EC 81 MG TABLET 62011-0019-01 0.01368 EACH 2025-01-22
HM ASPIRIN EC 81 MG TABLET 62011-0019-01 0.01317 EACH 2024-12-18
HM ASPIRIN EC 81 MG TABLET 62011-0019-01 0.01244 EACH 2024-11-20
HM ASPIRIN EC 81 MG TABLET 62011-0019-01 0.01411 EACH 2024-10-23
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Aspirin

Overview of the Aspirin Market

The aspirin market is a mature yet dynamic sector, driven by various factors that influence its growth and stability. Here’s a comprehensive analysis of the market, including its current state, future projections, and key drivers.

Market Size and Growth Projections

As of 2022, the global aspirin market was valued at approximately USD 2.356 billion[1][3][4].

  • Forecast to 2030: The market is expected to grow to around USD 2.917 billion by 2030, with a compound annual growth rate (CAGR) of about 2.70% between 2023 and 2030[1].
  • Alternative Forecast: Another projection suggests the market could reach USD 3.42 billion by 2030, growing at a CAGR of 4.62% from 2023 to 2030[4].

Key Drivers of Market Growth

Increasing Prevalence of Chronic Diseases

The rising global incidence of chronic diseases such as cardiovascular diseases, hypertension, and other inflammatory conditions is a significant driver of the aspirin market. Aspirin is widely used for its anti-inflammatory and antiplatelet properties, making it a staple in managing these conditions[1][3][4].

Growing Geriatric Population

The increasing geriatric population is another crucial factor. Older adults are more susceptible to chronic diseases, which in turn increases the demand for aspirin[4].

Expanding Applications

Aspirin's potential in cancer prevention and treatment of dementia is opening new therapeutic avenues. Research into these areas is expected to boost market growth[4].

Online and Offline Distribution Channels

The growth of online retail and e-commerce has significantly impacted the aspirin market. Online sales channels are growing at a high CAGR, driven by increasing internet penetration and consumer preference for online shopping, especially during the COVID-19 pandemic[3].

Market Restraints

Side Effects and Alternative Medications

Aspirin's gastrointestinal side effects and increased risk of bleeding are major restraints. Additionally, the availability of alternative medications with improved efficacy and fewer side effects poses a challenge to the market[1][4].

Regulatory Constraints

Stringent regulatory requirements for the approval of new formulations and applications of aspirin also limit market growth[4].

Regional Market Analysis

Asia-Pacific Region

The Asia-Pacific region, particularly China and India, is expected to witness the highest growth due to the robust pharmaceutical industry and large population base. These countries are leaders in the production of Active Pharmaceutical Ingredients (APIs) and have a high demand for basic medicines like aspirin[1][3].

Market Segmentation

By Application

The market is segmented into pain/fever/inflammation, cardiovascular disease, and other applications. The pain/fever/inflammation segment has seen the highest growth due to aspirin's primary function in relieving mild to moderate body aches and headaches[1].

By Distribution Channels

The market is categorized into online and offline sales channels. Offline channels currently hold a significant market share, but online channels are growing rapidly due to increased internet penetration and consumer preference for online shopping[3].

Price Trends and Projections

Current Prices

As of recent quarters, the price of aspirin has been around USD 3,380 per metric ton in the USA[2].

Future Projections

While specific price projections for aspirin are not provided, the overall market growth and increasing demand are likely to influence pricing. However, the impact of generic versions of aspirin, which are significantly cheaper than branded products, could stabilize or even reduce prices in some regions[3].

Key Players and Market Share

The aspirin market is led by several key players, including Bayer AG, Allegiant Health, Bal Pharma Limited, Cardinal Health, and others. These companies are focusing on innovation, R&D, and strategic partnerships to maintain and expand their market share[1][4].

Emerging Opportunities and Challenges

Research and Development

Investment in R&D to enhance formulations of aspirin, mitigate side effects, and explore new drug delivery systems is a significant opportunity. Companies are also exploring aspirin's anticancer properties and its potential in managing dementia[4].

Regulatory and Market Challenges

Companies must navigate stringent regulatory requirements and the emergence of alternative medications. Educational campaigns to boost consumer confidence and demand are also crucial for sustained growth[4].

Consumer Behavior and Healthcare Trends

Online Retailing

The COVID-19 pandemic highlighted the importance of online retailing, with Amazon sales of essential items, including aspirin, increasing significantly. This trend is expected to continue, driven by growing internet penetration and consumer convenience[3].

Generic Medicines

Generic versions of aspirin, which are around 80-85% cheaper than branded versions, play a critical role in offering cost-effective healthcare. This segment is expected to continue growing, especially in poorer countries where affordable healthcare is a significant concern[3].

Key Takeaways

  • Market Growth: The aspirin market is expected to grow at a CAGR of 2.70% to 4.62% from 2023 to 2030.
  • Key Drivers: Increasing prevalence of chronic diseases, growing geriatric population, and expanding applications.
  • Market Restraints: Side effects, alternative medications, and regulatory constraints.
  • Regional Growth: Asia-Pacific region, particularly China and India, is expected to witness the highest growth.
  • Price Trends: Current prices around USD 3,380 per metric ton in the USA, with future prices influenced by market growth and generic versions.

FAQs

Q: What is the current market size of the aspirin market?

A: The global aspirin market size was around USD 2.356 billion in 2022[1].

Q: What is the projected growth rate of the aspirin market?

A: The market is expected to grow at a CAGR of 2.70% to 4.62% from 2023 to 2030[1][4].

Q: Which region is expected to witness the highest growth in the aspirin market?

A: The Asia-Pacific region, particularly China and India, is expected to witness the highest growth[1][3].

Q: What are the main applications of aspirin in the market?

A: The main applications are pain/fever/inflammation, cardiovascular disease, and other applications[1].

Q: How are generic versions of aspirin impacting the market?

A: Generic versions are significantly cheaper and account for more than 80% of total medicines prescribed in several countries, contributing to market growth[3].

Sources

  1. Zion Market Research: Aspirin Market Size, Share, Value and Forecast 2030
  2. ChemAnalyst: Aspirin Prices, News, Monitor, Market Analysis & Demand
  3. ResearchAndMarkets: Aspirin Market - Forecasts from 2022 to 2027
  4. GlobeNewswire: The $3.42 Billion Aspirin Industry 2025-2030 - Emerging Opportunities in Aspirin's Anticancer and Dementia Research Drive Potential for R&D and Strategic Partnerships

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.